Artelo Biosciences (ARTL) Net Cash Flow (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Net Cash Flow of -$1.1 million for Q4 2025, up 44.48% year-over-year from -$772438.0 in Q4 2024, and down 267.11% quarter-over-quarter from -$304000.0 in Q3 2025.
Artelo Biosciences (ARTL) Net Cash Flow (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Net Cash Flow for 12 consecutive years, with -$1.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Cash Flow rose 44.48% year-over-year to -$1.1 million; the TTM figure through Dec 2025 stood at -$1.7 million (down 265.67% YoY), while the FY2025 annual figure was -$1.7 million, down 265.67% from the prior year.
- Net Cash Flow retreated to -$1.1 million in Q4 2025 per ARTL's latest filing, from -$304000.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $7.5 million in Q4 2021 and bottomed at -$4.8 million in Q3 2022.
- Historically, Net Cash Flow has averaged -$33335.6 across 5 years, with a median of -$338000.0 in 2022.
- Annual changes were most pronounced in 2024 — Net Cash Flow tumbled 12546.15% — and 2025, when it jumped 515.97%.
- Artelo Biosciences' Net Cash Flow stood at $7.5 million in 2021, then plunged by 104.87% to -$363000.0 in 2022, then soared by 148.76% to $177000.0 in 2023, then plunged by 1235.59% to -$2.0 million in 2024, then jumped by 44.48% to -$1.1 million in 2025.
- Business Quant data shows ARTL's Net Cash Flow at -$1.1 million in Q4 2025, -$304000.0 in Q3 2025, and $1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.12 Mn |
| Dec 31, 2025 | -1.12 Mn |
| Sep 30, 2025 | -304,000.00 |
| Sep 30, 2025 | -304,000.00 |
| Jun 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | -313,000.00 |
| Jun 30, 2024 | -313,000.00 |
| Mar 31, 2024 | -1.62 Mn |
| Mar 31, 2024 | -1.62 Mn |
| Dec 31, 2023 | 177,000.00 |
| Dec 31, 2023 | 177,000.00 |
| Sep 30, 2023 | -3.10 Mn |
| Sep 30, 2023 | -3.10 Mn |